Circulating tumor-derived DNA (ctDNA) clearance in patients with locally advanced rectal cancer treated with multimodal treatment

被引：0
|
作者：
Gervaso, L. [1 ]
Ciardiello, D. [2 ]
Ascione, L. [3 ]
Boldrini, L. [4 ,5 ]
Guidi, L. [6 ]
Valenza, C. [4 ,5 ]
Gregato, G. [3 ]
Funicelli, L. [3 ]
Bottiglieri, L. [3 ]
De Roberto, G. [3 ]
Petz, W. [6 ]
Borin, S. [6 ]
Romario, U. Fumagalli [3 ]
Gerardi, M. [3 ]
Bertolini, F. [3 ]
Curigliano, G. [4 ,5 ]
Fazio, N. [1 ]
Zampino, M. [1 ]
机构：
[1] IRCCS, European Inst Oncol, Div Gastrointestinal Med Oncol & Neuroendocrine T, Milan, Italy
[2] Fdn Giovanni Pascale, IRCCS Napoli, Ist Nazl Studio & Cura Tumori, Naples, Italy
[3] IRCCS, IEO, Milan, Italy
[4] European Inst Oncol IRCCS, IEO, Div Early Drug Dev Innovat Therapies, Milan, Italy
[5] Univ Milan, Milan, Italy
[6] IRCCS, European Inst Oncol, Div Digest Surg, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.04.152
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-96
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [41] Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with nivolumab
    Passiglia, F.
    Perez, A.
    Listi, A.
    Castiglia, M.
    Musso, E.
    Ancona, C.
    Rizzo, S.
    Alu, M.
    Blasi, L.
    Russo, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [42] Circulating Tumor DNA Predicts Pathologic and Clinical Outcomes Following Neoadjuvant Chemoradiation and Surgery for Patients With Locally Advanced Rectal Cancer
    McDuff, Susan G. R.
    Hardiman, Karin M.
    Ulintz, Peter J.
    Parikh, Aparna R.
    Zheng, Hui
    Kim, Daniel W.
    Lennerz, Jochen K.
    Hazar-Rethinam, Mehlika
    Van Seventer, Emily E.
    Fetter, Isobel J.
    Nadres, Brandon
    Eyler, Christine E.
    Ryan, David P.
    Weekes, Colin D.
    Clark, Jeffrey W.
    Cusack, James C.
    Goyal, Lipika
    Zhu, Andrew X.
    Wo, Jennifer Y.
    Blaszkowsky, Lawrence S.
    Allen, Jill
    Corcoran, Ryan B.
    Hong, Theodore S.
    JCO PRECISION ONCOLOGY, 2021, 5 : 123 - 132
  • [43] Circulating tumor DNA (ctDNA) for response assessment in patients with anal cancer treated with definitive chemoradiation.
    Alvarez, Janet
    Cercek, Andrea
    Mohan, Natasha
    Cuaron, John J.
    Zinovoy, Melissa
    Reyngold, Marsha
    Yaeger, Rona
    Hajj, Carla
    Fanta, Corrine
    Wong, Charles
    Segal, Neil Howard
    Paty, Philip
    Crane, Christopher H.
    Garcia-Aguilar, Julio
    Weiser, Martin R.
    Smith, Jesse Joshua
    Tuli, Richard
    Romesser, Paul Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 1 - 1
  • [44] Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma
    Schwaederle, Maria C.
    Patel, Sandip P.
    Husain, Hatim
    Ikeda, Megumi
    Lanman, Richard B.
    Banks, Kimberly C.
    Talasaz, AmirAli
    Bazhenova, Lyudmila
    Kurzrock, Razelle
    CLINICAL CANCER RESEARCH, 2017, 23 (17) : 5101 - 5111
  • [45] Biomarker analysis by next generation circulating tumor DNA (ctDNA) sequencing in patients with advanced breast cancer
    Li, Huiping
    Wang, Jing
    Rugo, Hope S.
    Zhang, Yan
    Yang, Ling
    Liu, Xiaoran
    Shao, Bin
    Xu, Yaping
    Yang, Liang
    Zhang, Ruyan
    Ran, Ran
    Chang, Lianpeng
    CANCER RESEARCH, 2018, 78 (04)
  • [46] Serial ctDNA (circulating tumour DNA) for detection of genomic changes during neoadjuvant chemoradiotherapy (NACRT) in locally advanced rectal cancer (LARC)
    Lee, C. L.
    Toomey, S.
    O'Neill, B.
    Hennessy, B. T.
    ANNALS OF ONCOLOGY, 2020, 31 : S423 - S424
  • [47] Using circulating tumor DNA (ctDNA) to predict surgical outcome and postoperative recurrence following neoadjuvant chemoradiation (CRT) for borderline resectable/locally advanced rectal cancer (LARC).
    McDuff, Susan G. R.
    Hardiman, Karin
    Parikh, Aparna Raj
    Ulintz, Peter
    Hazar-Rethinam, Mehlika
    Zheng, Hui
    Van Seventer, Emily
    Fetter, Isobel
    Nadres, Brandon
    Ryan, David P.
    Weekes, Colin D.
    Clark, Jeffrey W.
    Cusack, James C.
    Goyal, Lipika
    Zhu, Andrew X.
    Wo, Jennifer Yon-Li
    Blaszkowsky, Lawrence Scott
    Allen, Jill N.
    Corcoran, Ryan Bruce
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [48] Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
    Piercey, Oliver
    Tie, Jeanne
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [49] Using circulating tumor DNA (ctDNA) to predict surgical outcome after neoadjuvant chemoradiation for locally advanced pancreatic cancer (LAPC).
    McDuff, Susan
    Parikh, Aparna Raj
    Hazar-Rethinam, Mehlika
    Zheng, Hui
    Van Seventer, Emily
    Nadres, Brandon
    Ryan, David P.
    Weekes, Colin D.
    Clark, Jeffrey W.
    Fernandez-del Castillo, Carlos
    Ferrone, Cristina
    Lillemoe, Keith D.
    Murphy, Janet E.
    Goyal, Lipika
    Zhu, Andrew X.
    Wo, Jennifer Yon-Li
    Blaszkowsky, Lawrence Scott
    Allen, Jill N.
    Corcoran, Ryan Bruce
    Hong, Theodore S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [50] Treatment stratification and prognosis assessment using circulating tumor DNA in locally advanced rectal cancer: A systematic review and meta-analysis
    Mi, Junjie
    Wang, Rong
    Han, Xiaofang
    Ma, Ruijun
    Zhao, Danyu
    CANCER MEDICINE, 2023, 12 (17): : 17934 - 17944
12345